Sue (Ayt)
23rd February 2021, 16:22
We have several threads about the growing problem of autoimmune diseases, and the huge spectrum of labeled new "diseases" that have cropped up in recent years. This new pandemic almost seems to be manifesting as a mother-load of autoimmune disease instigators, judging by the growing number of symptoms being attributed to covid-19.
Makes one wonder if indeed this virus was manufactured, could new "diseases" be part of the motive for its release? (I noticed the two articles below upon doing a google news search on autoimmunity yesterday.)
Coronavirus-induced autoimmunity
Clin Immunol. 2021 Feb 18:108694. doi: 10.1016/j.clim.2021.108694. Online ahead of print.
ABSTRACT
The pandemic of Coronavirus disease 2019 (COVID-19), caused by a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spotlighted the link between viral infection and autoimmunity. In this review, we focus on coronavirusinduced autoimmunity based on evidence from experimental animal models, SARSCoV infection with in vitro studies of molecular mimicry and COVID-19 with several clinical reports of autoimmune manifestations of this disease. Further studies will be needed to better characterize the role of SARS-CoV-2 in the development of autoimmunity.
https://www.docwirenews.com/abstracts/coronavirus-induced-autoimmunity/
------------------
The SARS-CoV-2 as an instrumental trigger of autoimmunity
Autoimmun Rev. 2021 Feb 18:102792. doi: 10.1016/j.autrev.2021.102792. Online ahead of print.
ABSTRACT
Autoimmunity may be generated by a variety of factors by creating a hyper-stimulated state of the immune system. It had been established long ago that viruses are a substantial component of environmental factors that contribute to the production of autoimmune antibodies, as well as autoimmune diseases. Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) are viruses that withhold these autoimmune abilities. In a similar manner, SARS-CoV-2 may be counted to similar manifestations, as numerous records demonstrating the likelihood of COVID-19 patients to develop multiple types of autoantibodies and autoimmune diseases. In this review, we focused on the association between COVID-19 and the immune system concerning the tendency of patients to develop over 15 separate types of autoantibodies and above 10 distinct autoimmune diseases. An additional autoimmunity manifestation may be one of the common initial symptoms in COVID-19 patients, anosmia, the complete loss of the ability to sense smell, and other olfactory alterations. We summarize current knowledge on principal mechanisms that may contribute to the development of autoimmunity in the disease: the ability of SARS-CoV-2 to hyper-stimulate the immune system, induce excessive neutrophil extracellular traps formation with neutrophil-associated cytokine responses and the molecular resemblance between self-components of the host and the virus. Additionally, we will examine COVID-19 potential risk on the new-onsets of autoimmune diseases, such as antiphospholipid syndrome, Guillain-Barré syndrome, Kawasaki disease and numerous others. It is of great importance to recognize those autoimmune manifestations of COVID-19 in order to properly cope with their outcomes in the ongoing pandemic and the long-term post-pandemic period. Lastly, an effective vaccine against SARS-CoV-2 may be the best solution in dealing with the ongoing pandemic. We will discuss the new messenger RNA vaccination strategy with an emphasis on autoimmunity implications.
https://www.docwirenews.com/abstracts/the-sars-cov-2-as-an-instrumental-trigger-of-autoimmunity/
--------------
I have also noticed many biz/investment recommendations for investing in the fast growing autoimmunity drug markets, like this link:
Autoimmune Disease Diagnosis Market Changing Dynamics Of Competition With Forecast To 2030
Market Industry Reports (MIR) has published a new report titled “Autoimmune Disease Diagnosis Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the Global Autoimmune Disease Diagnosis Market is estimated to account for over US$ 3.5 billion in 2019. It is anticipated to grow at a CAGR of 8.6% CAGR from 2019 to 2030.
The steady growth of the autoimmune disease diagnosis market can be attributed to the rising incidences of autoimmune diseases worldwide, especially in the U.S., wherein, it is considered to be the major health crisis. According to Bingham Healthcare organization, more than 50 million Americans suffer from one or more autoimmune diseases. According to the Department of Health and Human Services’ Office of Women’s Health, autoimmune diseases and disorders are ranked in the first position in the top ten list. Along with its increase in awareness among people regarding autoimmune diseases through different research programs and education is helping people to treat the autoimmune diseases at early stage. Also, governments and NGOs are involved in creating awareness among people. Advancements in diagnostic technology along with improvements in laboratory automation are also driving market growth. Rising access to medical insurance will further boost market growth of the market significantly.
https://bisouv.com/uncategorized/113730/autoimmune-disease-diagnosis-market-changing-dynamics-of-competition-with-forecast-to-2030/
Makes one wonder if indeed this virus was manufactured, could new "diseases" be part of the motive for its release? (I noticed the two articles below upon doing a google news search on autoimmunity yesterday.)
Coronavirus-induced autoimmunity
Clin Immunol. 2021 Feb 18:108694. doi: 10.1016/j.clim.2021.108694. Online ahead of print.
ABSTRACT
The pandemic of Coronavirus disease 2019 (COVID-19), caused by a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spotlighted the link between viral infection and autoimmunity. In this review, we focus on coronavirusinduced autoimmunity based on evidence from experimental animal models, SARSCoV infection with in vitro studies of molecular mimicry and COVID-19 with several clinical reports of autoimmune manifestations of this disease. Further studies will be needed to better characterize the role of SARS-CoV-2 in the development of autoimmunity.
https://www.docwirenews.com/abstracts/coronavirus-induced-autoimmunity/
------------------
The SARS-CoV-2 as an instrumental trigger of autoimmunity
Autoimmun Rev. 2021 Feb 18:102792. doi: 10.1016/j.autrev.2021.102792. Online ahead of print.
ABSTRACT
Autoimmunity may be generated by a variety of factors by creating a hyper-stimulated state of the immune system. It had been established long ago that viruses are a substantial component of environmental factors that contribute to the production of autoimmune antibodies, as well as autoimmune diseases. Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) are viruses that withhold these autoimmune abilities. In a similar manner, SARS-CoV-2 may be counted to similar manifestations, as numerous records demonstrating the likelihood of COVID-19 patients to develop multiple types of autoantibodies and autoimmune diseases. In this review, we focused on the association between COVID-19 and the immune system concerning the tendency of patients to develop over 15 separate types of autoantibodies and above 10 distinct autoimmune diseases. An additional autoimmunity manifestation may be one of the common initial symptoms in COVID-19 patients, anosmia, the complete loss of the ability to sense smell, and other olfactory alterations. We summarize current knowledge on principal mechanisms that may contribute to the development of autoimmunity in the disease: the ability of SARS-CoV-2 to hyper-stimulate the immune system, induce excessive neutrophil extracellular traps formation with neutrophil-associated cytokine responses and the molecular resemblance between self-components of the host and the virus. Additionally, we will examine COVID-19 potential risk on the new-onsets of autoimmune diseases, such as antiphospholipid syndrome, Guillain-Barré syndrome, Kawasaki disease and numerous others. It is of great importance to recognize those autoimmune manifestations of COVID-19 in order to properly cope with their outcomes in the ongoing pandemic and the long-term post-pandemic period. Lastly, an effective vaccine against SARS-CoV-2 may be the best solution in dealing with the ongoing pandemic. We will discuss the new messenger RNA vaccination strategy with an emphasis on autoimmunity implications.
https://www.docwirenews.com/abstracts/the-sars-cov-2-as-an-instrumental-trigger-of-autoimmunity/
--------------
I have also noticed many biz/investment recommendations for investing in the fast growing autoimmunity drug markets, like this link:
Autoimmune Disease Diagnosis Market Changing Dynamics Of Competition With Forecast To 2030
Market Industry Reports (MIR) has published a new report titled “Autoimmune Disease Diagnosis Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the Global Autoimmune Disease Diagnosis Market is estimated to account for over US$ 3.5 billion in 2019. It is anticipated to grow at a CAGR of 8.6% CAGR from 2019 to 2030.
The steady growth of the autoimmune disease diagnosis market can be attributed to the rising incidences of autoimmune diseases worldwide, especially in the U.S., wherein, it is considered to be the major health crisis. According to Bingham Healthcare organization, more than 50 million Americans suffer from one or more autoimmune diseases. According to the Department of Health and Human Services’ Office of Women’s Health, autoimmune diseases and disorders are ranked in the first position in the top ten list. Along with its increase in awareness among people regarding autoimmune diseases through different research programs and education is helping people to treat the autoimmune diseases at early stage. Also, governments and NGOs are involved in creating awareness among people. Advancements in diagnostic technology along with improvements in laboratory automation are also driving market growth. Rising access to medical insurance will further boost market growth of the market significantly.
https://bisouv.com/uncategorized/113730/autoimmune-disease-diagnosis-market-changing-dynamics-of-competition-with-forecast-to-2030/